Home › Funds › Cormorant Asset Management, LP › CLYM
Cormorant Asset Management, LP position in CLYM
CLIMB BIO INC · Health Care
Cormorant Asset Management, LP reported holding 2,106,000 shares of CLYM (CLIMB BIO INC) in its Q3 2026 13F filing — a position valued at US$24.2M, representing 1.73% of its reported portfolio and ranking #19 among its reported holdings. Cormorant Asset Management, LP has disclosed CLYM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Cormorant Asset Management, LP's CLYM position evolved
Cormorant Asset Management, LP first disclosed a stake in CLYM in Q2 2026 at 2,106,000 shares (US$27.5M). Across 2 filings, Cormorant Asset Management, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 2,106,000 shares valued at US$24.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 2.11M | $27.46M | New |
| Q3 2026 | 2.11M | $24.16M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CLYM and 13F data
CLYM (CLIMB BIO INC) is a Health Care company. 68 other funds we track also report a position in CLYM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$116.2M), BRAIDWELL LP (US$32.8M), Redmile Group, LLC (US$11.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CLYM
- RA CAPITAL MANAGEMENT, L.P. 10.13M sh · $116.19M · Q3 2026
- BRAIDWELL LP 2.86M sh · $32.84M · Q3 2026
- Redmile Group, LLC 974.49K sh · $11.18M · Q3 2026
- Affinity Asset Advisors, LLC 972.00K sh · $11.15M · Q3 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 918.23K sh · $10.53M · Q3 2026
- GREAT POINT PARTNERS LLC 800.00K sh · $9.18M · Q3 2026
- SPHERA FUNDS MANAGEMENT LTD. 416.75K sh · $4.78M · Q3 2026
- NAN FUNG TRINITY (HK) Ltd 360.65K sh · $4.14M · Q3 2026
- ArchPoint Investors 132.90K sh · $1.52M · Q3 2026
- Exome Asset Management LLC 71.22K sh · $816.84K · Q3 2026
More on Cormorant Asset Management, LP
FAQ
How long has Cormorant Asset Management, LP held CLYM?
Cormorant Asset Management, LP has disclosed CLYM holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Cormorant Asset Management, LP's current position in CLYM?
As of Q3 2026, Cormorant Asset Management, LP holds 2.11M shares of CLYM (CLIMB BIO INC), valued at $24.16M, representing 1.73% of its reported portfolio and ranking #19.
Has Cormorant Asset Management, LP been buying or selling CLYM?
In the latest 13F filing (Q3 2026), Cormorant Asset Management, LP held unchanged its position in CLYM.
Which other funds hold CLYM?
Other major institutional holders of CLYM include RA CAPITAL MANAGEMENT, L.P., BRAIDWELL LP, Redmile Group, LLC, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.